IQV Stock Analysis: Buy, Sell, or Hold?
IQV - IQVIA Holdings Inc.
$207.55
-0.30 (-0.14%)
▼
5d:
+0.77%
30d:
+13.93%
90d:
+24.03%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 28, 2026
14d
Smart Money Distribution
None View Scanner →
Strength: 5.1/10
Get Alerted When IQV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: IQV shows positive signals but monitor for confirmation. Market pricing in 1.6% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: IQV shows positive signals but monitor for confirmation. Market pricing in 1.6% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$280.78
Based on 7.4% avg growth
INTRINSIC VALUE TODAY
$174.34
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IQV is currently trading at $207.55, which is considered extended relative to its 30-day fair value range of $176.09 to $202.56. The stock's valuation (Forward PE: 14.6) is in line with its historical norms (13.9). At these levels, the market is pricing in 1.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, IQV is in a strong uptrend. The price is approaching resistance at $190.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IQV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $229.63 (+10.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IQV is in a strong uptrend. The price is approaching resistance at $190.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IQV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $229.63 (+10.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$176.09 -
$202.56
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($229.63)
- NEUTRAL: Market pricing in 1.6% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$176.09 -
$202.56
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$163.02
Resistance Level
$190.68
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.63
Wall Street Target
$229.63
(+10.6%)
Revenue Growth (YoY)
8.4%
Earnings Growth (YoY)
15.0%
Profit Margin
8.3%
Valuation Premium vs History
+1.6% premium
PE vs Historical
14.6 vs 13.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.6%
(market-implied from PE analysis)
1-Year Target
$210.87
(+2%)
2-Year Target
$214.24
(+3%)
3-Year Target
$217.67
(+5%)
3-Yr Target (if PE normalizes)
(PE: 15→14)
PE COMPRESSION
$206.81
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 10.7%)
$419.48
(+102%)
Base:
(SPY PE: 14.6, Growth: 10.7%)
$281.78
(+36%)
Bear:
(PE: 12.4, Growth: 10.7%)
$239.51
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 26.16 | Current EPS (TTM): $8.05
Bull Case
$408.30
(+96%)
Analyst growth 76.2%, PE expands to 28.8
Base Case
$371.18
(+79%)
Market implied 76.2%, PE stable at 26.2
Bear Case
$143.23
(-31%)
Severe decline -20.0%, PE contracts to 22.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 13, 2026 5:48 PM ET
Data refreshes hourly during market hours. Next update: 6:48 PM
Data refreshes hourly during market hours. Next update: 6:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IQV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Kevin Hern
SELL
2026-03-16
Ro Khanna
SELL
2026-02-24
Ro Khanna
SELL
2026-01-29
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 67 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$157 | 60 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 54 HOLD |
Advanced IQV Option Strategies
Professional options setups generated by AI based on today's IQV price and gamma walls.
